tm
Seeing Is Believing
tm
Seeing Is Believing
IKT is currently covered by 1 analysts with an average price target of $8. This is a potential upside of $6.15 (332.43%) from yesterday's end of day stock price of $1.85.
Inhibikase Therapeutics's activity chart (see below) currently has 2 price targets and 11 ratings on display. The stock rating distribution of IKT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 12.96% with an average time for these price targets to be met of 88.33 days.
Highest price target for IKT is $8, Lowest price target is $8, average price target is $8.
Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 08-Apr-2026. First documented stock forecast 13-Jan-2020.
Currently out of the existing stock ratings of IKT, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Dec-2025
$8
$6.03 (306.09%)
$8
6 months 6 days ago
(08-Apr-2026)
0/2 (0%)
$6.26 (359.77%)
Hold Since 31-Mar-2025
1 years 6 months 13 days ago
(31-Mar-2025)
0/2 (0%)
$3.41 (214.47%)
Hold Since 16-Nov-2022
$72
3 years 10 months 28 days ago
(16-Nov-2022)
0/1 (0%)
$56.82 (374.31%)
Sell Since 07-Mar-2021
4 years 2 months 13 days ago
(01-Aug-2022)
0/2 (0%)
$46.55 (145.02%)
Buy Since 02-Mar-2021
$90.25
4 years 4 months 17 days ago
(27-May-2022)
2/6 (33.33%)
$51.91 (135.39%)
256
What is IKT (Inhibikase Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on IKT (Inhibikase Therapeutics)?
Which analyst has the current lower performing score on IKT (Inhibikase Therapeutics) with a proven track record?
Which analyst has the most public recommendations on IKT (Inhibikase Therapeutics)?
Which analyst is the currently most bullish on IKT (Inhibikase Therapeutics)?
Which analyst is the currently most reserved on IKT (Inhibikase Therapeutics)?
